| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-11 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.29 | 5e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |